Literature DB >> 19026486

Mislocalization of cell-cell adhesion complexes in tamoxifen-resistant breast cancer cells with elevated c-Src tyrosine kinase activity.

Yan Zhao1, Maricarmen D Planas-Silva.   

Abstract

c-Src activation has been implicated in metastasis of tamoxifen-resistant breast cancer. Here we investigated how c-Src activity affects cell adhesion using a tamoxifen-resistant variant of MCF-7 cells (MTR-3) containing elevated c-Src activity. In MTR-3 cells, adhesion proteins beta-catenin and E-cadherin are mislocalized, forming novel structures perpendicular to cell-cell junctions. c-Src is associated with beta-catenin/E-cadherin complexes and beta-catenin tyrosine phosphorylation is enhanced. Blocking c-Src tyrosine kinase activity decreased beta-catenin tyrosine phosphorylation and restored localization of beta-catenin and E-cadherin at cell-cell junctions. These findings suggest that inhibition of c-Src signaling may prevent metastasis of tamoxifen-resistant breast cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19026486     DOI: 10.1016/j.canlet.2008.10.022

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  9 in total

1.  Progesterone regulation of tissue factor depends on MEK1/2 activation and requires the proline-rich site on progesterone receptor.

Authors:  Maria Loreto Bravo; Mauricio P Pinto; Ibeth Gonzalez; Barbara Oliva; Sumie Kato; Mauricio A Cuello; Carol A Lange; Gareth I Owen
Journal:  Endocrine       Date:  2014-05-23       Impact factor: 3.633

Review 2.  MUC1-mediated motility in breast cancer: a review highlighting the role of the MUC1/ICAM-1/Src signaling triad.

Authors:  Lacey Haddon; Judith Hugh
Journal:  Clin Exp Metastasis       Date:  2015-03-11       Impact factor: 5.150

3.  Role of endoplasmic reticulum stress in epithelial-mesenchymal transition of alveolar epithelial cells: effects of misfolded surfactant protein.

Authors:  Qian Zhong; Beiyun Zhou; David K Ann; Parviz Minoo; Yixin Liu; Agnes Banfalvi; Manda S Krishnaveni; Mickael Dubourd; Lucas Demaio; Brigham C Willis; Kwang-Jin Kim; Roland M duBois; Edward D Crandall; Michael F Beers; Zea Borok
Journal:  Am J Respir Cell Mol Biol       Date:  2010-12-17       Impact factor: 6.914

Review 4.  Meaningful prevention of breast cancer metastasis: candidate therapeutics, preclinical validation, and clinical trial concerns.

Authors:  Alexandra S Zimmer; Patricia S Steeg
Journal:  J Mol Med (Berl)       Date:  2014-11-22       Impact factor: 4.599

5.  Modulating therapeutic effects of the c-Src inhibitor via oestrogen receptor and human epidermal growth factor receptor 2 in breast cancer cell lines.

Authors:  Ping Fan; Russell E McDaniel; Helen R Kim; Dionyssia Clagett; Bassem Haddad; V Craig Jordan
Journal:  Eur J Cancer       Date:  2012-06-02       Impact factor: 9.162

6.  Elevated c-Src and c-Yes expression in malignant skin cancers.

Authors:  Jang Hyun Lee; Jae-Kyung Pyon; Dong Wook Kim; Sang Han Lee; Hae Seon Nam; Chul Han Kim; Sang Gue Kang; Yoon Jin Lee; Mi Youn Park; Dong Jun Jeong; Moon Kyun Cho
Journal:  J Exp Clin Cancer Res       Date:  2010-08-27

7.  New insights into acquired endocrine resistance of breast cancer.

Authors:  Ping Fan; V Craig Jordan
Journal:  Cancer Drug Resist       Date:  2019-06-19

8.  SRC Promotes Tamoxifen Resistance in Breast Cancer via Up-Regulating SIRT1.

Authors:  Jun Zhou; Ming Xu; Kehao Le; Jie Ming; Hui Guo; Shengnan Ruan; Tao Huang
Journal:  Onco Targets Ther       Date:  2020-05-25       Impact factor: 4.147

9.  Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan.

Authors:  Stephen Hiscox; Bedanta Baruha; Chris Smith; Rebecca Bellerby; Lindy Goddard; Nicola Jordan; Zaruhi Poghosyan; Robert I Nicholson; Peter Barrett-Lee; Julia Gee
Journal:  BMC Cancer       Date:  2012-10-06       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.